• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SENP1 通过抑制 RIPK1 驱动的细胞凋亡和炎症来预防脂肪性肝炎。

SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation.

机构信息

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, 201210, China.

University of Chinese Academy of Sciences, Beijing, 100049, China.

出版信息

Nat Commun. 2022 Nov 22;13(1):7153. doi: 10.1038/s41467-022-34993-0.

DOI:10.1038/s41467-022-34993-0
PMID:36414671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9681887/
Abstract

Activation of RIPK1-driven cell death and inflammation play important roles in the progression of nonalcoholic steatohepatitis (NASH). However, the mechanism underlying RIPK1 activation in NASH remains unclear. Here we identified SENP1, a SUMO-specific protease, as a key endogenous inhibitor of RIPK1. SENP1 is progressively reduced in proportion to NASH severity in patients. Hepatocyte-specific SENP1-knockout mice develop spontaneous NASH-related phenotypes in a RIPK1 kinase-dependent manner. We demonstrate that SENP1 deficiency sensitizes cells to RIPK1 kinase-dependent apoptosis by promoting RIPK1 activation following TNFα stimulation. Mechanistically, SENP1 deSUMOylates RIPK1 in TNF-R1 signaling complex (TNF-RSC), keeping RIPK1 in check. Loss of SENP1 leads to SUMOylation of RIPK1, which re-orchestrates TNF-RSC and modulates the ubiquitination patterns and activity of RIPK1. Notably, genetic inhibition of RIPK1 effectively reverses disease progression in hepatocyte-specific SENP1-knockout male mice with high-fat-diet-induced nonalcoholic fatty liver. We propose that deSUMOylation of RIPK1 by SENP1 provides a pathophysiologically relevant cell death-restricting checkpoint that modulates RIPK1 activation in the pathogenesis of nonalcoholic steatohepatitis.

摘要

RIPK1 驱动的细胞死亡和炎症的激活在非酒精性脂肪性肝炎(NASH)的进展中起着重要作用。然而,NASH 中 RIPK1 激活的机制尚不清楚。在这里,我们鉴定了 SENP1,一种 SUMO 特异性蛋白酶,作为 RIPK1 的关键内源性抑制剂。SENP1 的比例随着患者 NASH 严重程度的增加而逐渐降低。肝细胞特异性 SENP1 敲除小鼠以 RIPK1 激酶依赖性方式自发发展出与 NASH 相关的表型。我们证明,SENP1 缺乏通过促进 TNFα 刺激后的 RIPK1 激活,使细胞对 RIPK1 激酶依赖性凋亡敏感。在机制上,SENP1 在 TNF-R1 信号转导复合物(TNF-RSC)中去 SUMO 化 RIPK1,从而抑制 RIPK1。SENP1 的缺失导致 RIPK1 的 SUMO 化,这重新调整了 TNF-RSC,并调节了 RIPK1 的泛素化模式和活性。值得注意的是,RIPK1 的遗传抑制可有效逆转高脂肪饮食诱导的非酒精性脂肪肝中肝细胞特异性 SENP1 敲除雄性小鼠的疾病进展。我们提出,SENP1 对 RIPK1 的去 SUMO 化提供了一个与生理相关的细胞死亡限制检查点,调节了 RIPK1 在非酒精性脂肪性肝炎发病机制中的激活。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/fed5d2775b54/41467_2022_34993_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/5063d858f81d/41467_2022_34993_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/766977aac5bb/41467_2022_34993_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/820b730bfdca/41467_2022_34993_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/3dd5b31a4dbd/41467_2022_34993_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/84f2b7cc7d66/41467_2022_34993_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/ce1e4b0a1836/41467_2022_34993_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/9741083e6a5c/41467_2022_34993_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/fed5d2775b54/41467_2022_34993_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/5063d858f81d/41467_2022_34993_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/766977aac5bb/41467_2022_34993_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/820b730bfdca/41467_2022_34993_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/3dd5b31a4dbd/41467_2022_34993_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/84f2b7cc7d66/41467_2022_34993_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/ce1e4b0a1836/41467_2022_34993_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/9741083e6a5c/41467_2022_34993_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5e0/9681887/fed5d2775b54/41467_2022_34993_Fig8_HTML.jpg

相似文献

1
SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation.SENP1 通过抑制 RIPK1 驱动的细胞凋亡和炎症来预防脂肪性肝炎。
Nat Commun. 2022 Nov 22;13(1):7153. doi: 10.1038/s41467-022-34993-0.
2
UDP-glucuronate metabolism controls RIPK1-driven liver damage in nonalcoholic steatohepatitis.UDP-葡萄糖醛酸代谢控制非酒精性脂肪性肝炎中 RIPK1 驱动的肝损伤。
Nat Commun. 2023 May 11;14(1):2715. doi: 10.1038/s41467-023-38371-2.
3
Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.抑制受体相互作用蛋白激酶1可改善实验性非酒精性脂肪性肝病。
J Hepatol. 2020 Apr;72(4):627-635. doi: 10.1016/j.jhep.2019.11.008. Epub 2019 Nov 21.
4
SPATA2 regulates the activation of RIPK1 by modulating linear ubiquitination.SPATA2通过调节线性泛素化来调控RIPK1的激活。
Genes Dev. 2017 Jun 1;31(11):1162-1176. doi: 10.1101/gad.299776.117. Epub 2017 Jul 12.
5
Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms.肝实质细胞中受体相互作用蛋白激酶-1 的缺失促进了 NASH 小鼠的肝纤维化,而不影响其他症状。
J Mol Med (Berl). 2022 Jul;100(7):1027-1038. doi: 10.1007/s00109-022-02192-5. Epub 2022 Apr 27.
6
Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners.RIPK1 的泛素化以不同的方式调节其受 TNFR1 和 TLRs 信号转导调控的激活。
Nat Commun. 2020 Dec 11;11(1):6364. doi: 10.1038/s41467-020-19935-y.
7
NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis.NEMO通过抑制RIPK1激酶活性介导的肝细胞凋亡来预防脂肪性肝炎和肝细胞癌。
Cancer Cell. 2015 Nov 9;28(5):582-598. doi: 10.1016/j.ccell.2015.10.001.
8
RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis.RIPK1 保护肝细胞免受模式识别受体诱导的肝炎小鼠模型中库普弗细胞介导的 TNF 诱导的细胞凋亡。
J Hepatol. 2017 Jun;66(6):1205-1213. doi: 10.1016/j.jhep.2017.01.005. Epub 2017 Jan 11.
9
RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.RIP1 激酶活性通过调节巨噬细胞的细胞死亡和炎症反应促进脂肪性肝炎的发生。
Cell Death Differ. 2021 Apr;28(4):1418-1433. doi: 10.1038/s41418-020-00668-w. Epub 2020 Nov 18.
10
SENP1 mediates TNF-induced desumoylation and cytoplasmic translocation of HIPK1 to enhance ASK1-dependent apoptosis.SENP1介导肿瘤坏死因子诱导的HIPK1去SUMO化和细胞质易位,以增强ASK1依赖性凋亡。
Cell Death Differ. 2008 Apr;15(4):739-50. doi: 10.1038/sj.cdd.4402303. Epub 2008 Jan 25.

引用本文的文献

1
Liraglutide inhibits the development of colorectal cancer by regulating TGF-β/Smad3 signaling pathway and affecting epithelial-mesenchymal transition.利拉鲁肽通过调节TGF-β/Smad3信号通路和影响上皮-间质转化来抑制结直肠癌的发展。
Discov Oncol. 2025 Jul 18;16(1):1371. doi: 10.1007/s12672-025-03223-6.
2
Role of S-palmitoylation in digestive system diseases.S-棕榈酰化在消化系统疾病中的作用。
Cell Death Discov. 2025 Jul 18;11(1):331. doi: 10.1038/s41420-025-02629-z.
3
Killing hepatocellular carcinoma in the NAFLD/NASH stage: a comprehensive perspective on targeting regulated cell death.

本文引用的文献

1
Genetic Regulation of RIPK1 and Necroptosis.RIPK1与坏死性凋亡的基因调控
Annu Rev Genet. 2021 Nov 23;55:235-263. doi: 10.1146/annurev-genet-071719-022748.
2
Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies.非酒精性脂肪性肝炎中的肿瘤坏死因子-α信号传导与靶向治疗
J Genet Genomics. 2022 Apr;49(4):269-278. doi: 10.1016/j.jgg.2021.09.009. Epub 2021 Oct 28.
3
Hepatic Small Ubiquitin-Related Modifier (SUMO)-Specific Protease 2 Controls Systemic Metabolism Through SUMOylation-Dependent Regulation of Liver-Adipose Tissue Crosstalk.
在非酒精性脂肪性肝病/非酒精性脂肪性肝炎阶段杀死肝细胞癌:关于靶向程序性细胞死亡的全面观点
Cell Death Discov. 2025 Jun 19;11(1):281. doi: 10.1038/s41420-025-02558-x.
4
The ubiquitin-proteasome system: A potential target for the MASLD.泛素-蛋白酶体系统:代谢相关脂肪性肝病的一个潜在靶点。
Acta Pharm Sin B. 2025 Mar;15(3):1268-1280. doi: 10.1016/j.apsb.2025.01.010. Epub 2025 Jan 22.
5
The Role of Post-Translational Modifications in Necroptosis.翻译后修饰在坏死性凋亡中的作用
Biomolecules. 2025 Apr 9;15(4):549. doi: 10.3390/biom15040549.
6
Hypoxia-mediated SUMOylation of FADD exacerbates endothelial cell injury via the RIPK1-RIPK3-MLKL signaling axis.缺氧介导的FADD SUMO化通过RIPK1-RIPK3-MLKL信号轴加剧内皮细胞损伤。
Cell Death Dis. 2025 Feb 21;16(1):121. doi: 10.1038/s41419-025-07441-2.
7
New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses.肺动脉高压的新见解:PAN细胞焦亡与血管周围炎症反应之间的相互作用
Apoptosis. 2025 Feb 20. doi: 10.1007/s10495-025-02086-0.
8
Role of hepatocyte RIPK1 in maintaining liver homeostasis during metabolic challenges.肝细胞RIPK1在代谢应激期间维持肝脏稳态中的作用。
Elife. 2025 Jan 31;13:RP96798. doi: 10.7554/eLife.96798.
9
SENP1 inhibits aerobic glycolysis in Aβ-incubated astrocytes by promoting PUM2 deSUMOylation.SENP1通过促进PUM2去SUMO化来抑制Aβ孵育的星形胶质细胞中的有氧糖酵解。
Cell Biol Toxicol. 2025 Jan 10;41(1):28. doi: 10.1007/s10565-025-09986-6.
10
Tissue adaptation to metabolic stress: insights from SUMOylation.组织对代谢应激的适应:SUMOylation 的见解。
Front Endocrinol (Lausanne). 2024 Nov 11;15:1434338. doi: 10.3389/fendo.2024.1434338. eCollection 2024.
肝小泛素相关修饰蛋白酶 2 通过 SUMOylation 依赖的肝脂肪组织串扰调控来控制全身代谢。
Hepatology. 2021 Oct;74(4):1864-1883. doi: 10.1002/hep.31881. Epub 2021 Sep 9.
4
RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages.RIP1 激酶活性通过调节巨噬细胞的细胞死亡和炎症反应促进脂肪性肝炎的发生。
Cell Death Differ. 2021 Apr;28(4):1418-1433. doi: 10.1038/s41418-020-00668-w. Epub 2020 Nov 18.
5
RIPK1 ubiquitination: Evidence, correlations and the undefined.RIPK1 泛素化:证据、关联和未定义。
Semin Cell Dev Biol. 2021 Jan;109:76-85. doi: 10.1016/j.semcdb.2020.08.008. Epub 2020 Sep 23.
6
Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.肝实质细胞特异性 TAK1 缺乏导致 RIPK1 激酶依赖性炎症,从而促进肝纤维化和肝细胞癌。
Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14231-14242. doi: 10.1073/pnas.2005353117. Epub 2020 Jun 8.
7
TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice.TNF 受体 1 抑制可减少非酒精性脂肪性肝病小鼠的肝脂肪变性、肝细胞损伤和纤维化。
Cell Death Dis. 2020 Mar 31;11(3):212. doi: 10.1038/s41419-020-2411-6.
8
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis.AMPK-caspase-6 轴控制非酒精性脂肪性肝炎中的肝损伤。
Science. 2020 Feb 7;367(6478):652-660. doi: 10.1126/science.aay0542.
9
RIPK1 Kinase-Dependent Death: A Symphony of Phosphorylation Events.受体相互作用蛋白激酶1(RIPK1)依赖性死亡:磷酸化事件的交响曲
Trends Cell Biol. 2020 Mar;30(3):189-200. doi: 10.1016/j.tcb.2019.12.009. Epub 2020 Jan 17.
10
SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis.SUMOylation 抑制剂与 FXR 激动剂协同作用抗肝纤维化。
Nat Commun. 2020 Jan 13;11(1):240. doi: 10.1038/s41467-019-14138-6.